- Papers in database
- 3
- Primary author
- 1 paper
- Years active
- 2020 – 2025
- Health outcomes studied
- 1
Health Outcomes Studied
Papers (3)
- 2025Randomised double-blind placebo-controlled trial protocol to evaluate the therapeutic efficacy of lyophilised faecal microbiota capsules amended with next-generation beneficial bacteria in individuals with metabolic dysfunction-associated steatohepatitis.10.1136/bmjopen-2024-088290
- 2022Primary authorFrom fecal microbiota transplantation toward next-generation beneficial microbes: The case of Anaerobutyricum soehngenii10.3389/fmed.2022.1077275
- 2020Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose–response effects on glucose metabolism in human subjects with metabolic syndrome10.1038/s41522-020-0127-0